Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Curr Opin Nephrol Hypertens. 2017 May;26(3):154–164. doi: 10.1097/MNH.0000000000000311

Table 1.

Summary of published studies on parietal epithelial cells (PEC) as adult podocyte progenitors

Model System Data supporting PEC as adult podocyte progenitors Reference
Studies strongly supporting PECs as adolescent podocyte progenitors PEC reporter mice
  • A subset of labeled PECs is detected in the glomerular tuft in newborn and adolescent mice and co-express podocyte markers

  • Labeled PECs migrate to the glomerular tuft following podocyte depletion, augmented by administering a GSK3 inhibitor

[62]
[37]
Human kidney
  • A subpopulation of PECs at tubular pole co-stains for the stem/progenitor markers CD133/CD24

  • When these cells are isolated, and grown ex vivo, they have self-renewal potential and high cloning efficiency

  • Under certain culture conditions they acquire podocyte phenotypic features

  • Cells harvested from normal kidneys that double-labeled for PEC and stem/progenitor markers improved disease outcomes when injected into mice with experimental FSGS

[53]
[45]
[55]
Studies suggesting, but not definitively proving, that a subset of PECs are adult podocyte progenitors Rat model
  • ACE-inhibition affects a subset of cells lining Bowman’s capsule that co-express PEC proteins and NCAM (used as a differentiation marker)

[28]
Diabetic mouse
  • Blockade of the chemokine stromal-derived factor (SFD/CXCL12) enhanced the differentiation of renal progenitors towards a podocyte phenotype

[56]